Department of Defense Chemical, Biological, Radiological, and Nuclear Defense Program: Annual Report to Congress, May 2004   [open pdf - 7MB]

"In accordance with 50 USC 1523, this report provides Congress with an assessment of the overall readiness of the Armed Forces to fight in a chemical and biological warfare environment. [...] This Annual Report of the Department of Defense (DoD) Chemical, Biological, Radiological, and Nuclear (CBRN) Defense Program, or CBRNDP, provides information in response to several reporting requirements. First, this report is provided in accordance with 50 USC 1523. [...] This report supplements the DoD Chemical and Biological Defense Program FY05 President's budget, February 2004, which has been submitted to Congress. Second, section 2.7 of this report addresses the requirement to provide information on the costs incurred by, and payments made to, each contractor or other entity engaged in the production, storage, distribution, or marketing of the anthrax vaccine administered by the Department of Defense. Third, in response to a reporting requirement by the Senate Armed Services Committee, DoD provides a report, which includes an analysis of the capacity and versatility of the test and evaluation (T&E) infrastructure to meet the requirements of current and planned chemical and biological defense research and development programs, including facilities for testing equipment with live agents and simulants and for animal testing; and, an identification of any actions needed to meet testing requirements."

Public Domain
Retrieved From:
United States Chemical and Biological Defense Program: http://www.acq.osd.mil/cp/cbd.html
Media Type:
Help with citations